Dirk Ramaekers
Belgium
Research Article
Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes: Systematic Review
Author(s): Irina Odnoletkova, Geert Goderis, Lore Pil, Frank Nobels, Bert Aertgeerts, Lieven Annemans and Dirk RamaekersIrina Odnoletkova, Geert Goderis, Lore Pil, Frank Nobels, Bert Aertgeerts, Lieven Annemans and Dirk Ramaekers
Objective: To update current evidence on the cost-effectiveness (CE) of therapeutic education in prediabetes and type 2 diabetes. Research design and methods: A systematic review of economic evaluations of therapeutic education in prediabetes and type 2 diabetes, based on Randomized Controlled Trials (RCTs) and published in 2002 - 2014. The quality of the clinical evidence was appraised through the Cochrane Collaboration’s tool for assessing risk of bias. Economic studies were evaluated through the Consensus Health Economic Criteria List. The Incremental Cost- Effectiveness Ratios (ICERs) of patient education in prediabetes and type 2 diabetes were compared. Results: Out of 2031 identified publications, eight studies on prediabetes and nine on type 2 diabetes met the inclusion criteria. The level of the underlying clinical evide.. View More»
